Total Payments
$1,573
2021 Payments
$489.03
Companies
21
Transactions
83
Medicare Patients
1,064
Medicare Billing
$75,934
Payment Breakdown by Category
Food & Beverage$1,573 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,573 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $332.71 | 21 | $0 (2021) |
| Galderma Laboratories, L.P. | $219.56 | 12 | $0 (2021) |
| GlaxoSmithKline, LLC. | $132.05 | 2 | $0 (2021) |
| LEO Pharma Inc. | $123.62 | 8 | $0 (2021) |
| GENZYME CORPORATION | $104.74 | 6 | $0 (2021) |
| VYNE Pharmaceuticals Inc. | $95.53 | 5 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $81.19 | 6 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $75.73 | 4 | $0 (2021) |
| MAYNE PHARMA INC. | $70.67 | 3 | $0 (2020) |
| Lilly USA, LLC | $59.70 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $489.03 | 28 | AbbVie Inc. ($147.96) |
| 2020 | $746.82 | 35 | Galderma Laboratories, L.P. ($127.87) |
| 2019 | $291.52 | 17 | Galderma Laboratories, L.P. ($56.16) |
| 2018 | $33.74 | 2 | AbbVie, Inc. ($33.74) |
| 2017 | $11.64 | 1 | AbbVie, Inc. ($11.64) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Inflammation | ||||||
| 09/04/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Dermatology | ||||||
| 08/28/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Treatment of Rosacea | ||||||
| 08/11/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $17.39 | General |
| 07/28/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Ilumya (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Dermatology | ||||||
| 07/17/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2021 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology | ||||||
| 07/07/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: DERMATOLOGY | ||||||
| 06/10/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: DERMATOLOGY | ||||||
| 05/10/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $38.73 | General |
| Category: Immunology | ||||||
| 05/07/2021 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: DERMATOLOGY | ||||||
| 04/28/2021 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: ACNE | ||||||
| 04/09/2021 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/30/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Treatment of Rosacea | ||||||
| 03/19/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: IMMUNOLOGY | ||||||
| 02/05/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/22/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 564 | 832 | $125,077 | $41,354 |
| 2020 | 10 | 500 | 691 | $104,564 | $34,579 |
Total Patients
1,064
Total Services
1,523
Medicare Billing
$75,934
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 106 | $26,823 | $9,394 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 118 | 156 | $27,819 | $9,155 | 32.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 65 | 77 | $17,165 | $5,818 | 33.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 84 | 116 | $14,964 | $4,448 | 29.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,570 | $3,181 | 37.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 49 | 49 | $10,660 | $2,933 | 27.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 42 | 45 | $9,119 | $2,926 | 32.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 33 | 35 | $3,841 | $1,290 | 33.6% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 13 | 14 | $3,475 | $1,191 | 34.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 55 | 207 | $2,642 | $1,018 | 38.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 101 | 143 | $20,796 | $6,890 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 80 | $17,000 | $6,361 | 37.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 60 | 66 | $14,350 | $4,631 | 32.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 68 | 68 | $14,215 | $3,988 | 28.1% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 15 | 16 | $9,467 | $3,832 | 40.5% |
| 17000 | Destruction of skin growth | Office | 2020 | 66 | 86 | $11,252 | $3,126 | 27.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 41 | 43 | $8,434 | $2,680 | 31.8% |
| 11104 | Punch biopsy of single skin lesion | Office | 2020 | 15 | 15 | $3,687 | $1,253 | 34.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 24 | 24 | $3,498 | $1,138 | 32.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 41 | 150 | $1,863 | $680.60 | 36.5% |
About Dr. Edward Keuer, MD
Dr. Edward Keuer, MD is a Dermatology healthcare provider based in Oakbrook Terrace, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013995679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Keuer, MD has received a total of $1,573 in payments from pharmaceutical and medical device companies, with $489.03 received in 2021. These payments were reported across 83 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,573).
As a Medicare-enrolled provider, Keuer has provided services to 1,064 Medicare beneficiaries, totaling 1,523 services with total Medicare billing of $75,934. Data is available for 2 years (2020–2021), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Specialist
- Location Oakbrook Terrace, IL
- Active Since 01/04/2006
- Last Updated 07/14/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013995679
Products in Payments
- DUPIXENT (Biological) $145.89
- BENLYSTA (Biological) $132.05
- ENSTILAR (Drug) $123.62
- SKYRIZI (Biological) $110.50
- AKLIEF (Drug) $108.86
- HUMIRA (Biological) $106.47
- Humira (Biological) $98.35
- DORYX (Drug) $70.67
- TALTZ (Drug) $59.70
- ZILXI (Drug) $59.08
- ILUMYA (Biological) $42.66
- ORACEA (Drug) $41.35
- DUPIXENT (Drug) $40.04
- REMICADE (Biological) $38.73
- EPIDUO FORTE (Drug) $37.93
- AMZEEQ (Drug) $36.45
- Ilumya (Biological) $33.07
- Cimzia (Drug) $32.20
- EUCRISA (Drug) $31.81
- SOOLANTRA (Drug) $31.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.